{"id":14265,"date":"2023-09-05T22:50:00","date_gmt":"2023-09-05T14:50:00","guid":{"rendered":"https:\/\/flcube.com\/?p=14265"},"modified":"2024-11-22T23:10:56","modified_gmt":"2024-11-22T15:10:56","slug":"shanghai-pharmaceuticals-executives-under-investigation-for-serious-disciplinary-violations","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=14265","title":{"rendered":"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations"},"content":{"rendered":"\n

China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607<\/a>; SHA: 601607<\/a>) has disclosed that several former executives are suspected of serious violations of discipline and law. Pan Deqing, the company’s former vice-president, Chen Binhua, former general manager of subsidiary SPH NO.1 Biochemical & Pharmaceutical Co., Ltd, and Li Ping, former general manager of subsidiary Shanghai Shangke Pharmaceutical Co., Ltd, are currently undergoing disciplinary review and supervisory investigation by the Minhang district commissions for discipline inspection and supervision in Shanghai. Additionally, Huang Zhenhui, former deputy general manager of SPH NO.1 Biochemical & Pharmaceutical, is being investigated by the Minhang district supervisory committee. As of the announcement date, none of the individuals mentioned are employed by SPH.<\/p>\n\n\n\n

Resignations and Early Departures<\/strong>
SPH announced on September 2, 2023, that the board of directors received a written resignation from Pan Deqing. Due to personal reasons, Pan Deqing resigned from his position as VP of SPH and all roles within its subsidiaries. His term was initially expected to last for three years from March 2022, but he left the company after only 1.5 years, prior to the official retirement age of 60. Pan had also served as the director of SPH’s marketing center. Li Pingyue resigned over a month ago, and Chen Binhua retired early.<\/p>\n\n\n\n

Anti-Corruption Campaign in China’s Pharmaceutical Industry<\/strong>
The development follows an ongoing anti-corruption campaign that began in July 2023, targeting China’s pharmaceutical industry. By mid-August, more than 180 hospital presidents and party secretaries had reportedly been put under investigation. Several significant bribery cases have been uncovered and reported, highlighting the scale of the crackdown on corruption within the sector.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) has disclosed that several…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[890,891,196,691],"class_list":["post-14265","post","type-post","status-publish","format-standard","hentry","category-company","tag-hkg-2607","tag-sha-601607","tag-shanghai-pharmaceuticals","tag-sph"],"yoast_head":"\nShanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) has disclosed that several former executives are suspected of serious violations of discipline and law. Pan Deqing, the company's former vice-president, Chen Binhua, former general manager of subsidiary SPH NO.1 Biochemical & Pharmaceutical Co., Ltd, and Li Ping, former general manager of subsidiary Shanghai Shangke Pharmaceutical Co., Ltd, are currently undergoing disciplinary review and supervisory investigation by the Minhang district commissions for discipline inspection and supervision in Shanghai. Additionally, Huang Zhenhui, former deputy general manager of SPH NO.1 Biochemical & Pharmaceutical, is being investigated by the Minhang district supervisory committee. As of the announcement date, none of the individuals mentioned are employed by SPH.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=14265\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=14265\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-05T14:50:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-22T15:10:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=14265#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=14265\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations\",\"datePublished\":\"2023-09-05T14:50:00+00:00\",\"dateModified\":\"2024-11-22T15:10:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=14265\"},\"wordCount\":276,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"HKG: 2607\",\"SHA: 601607\",\"Shanghai Pharmaceuticals\",\"SPH\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=14265#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=14265\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=14265\",\"name\":\"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-09-05T14:50:00+00:00\",\"dateModified\":\"2024-11-22T15:10:56+00:00\",\"description\":\"China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) has disclosed that several former executives are suspected of serious violations of discipline and law. Pan Deqing, the company's former vice-president, Chen Binhua, former general manager of subsidiary SPH NO.1 Biochemical & Pharmaceutical Co., Ltd, and Li Ping, former general manager of subsidiary Shanghai Shangke Pharmaceutical Co., Ltd, are currently undergoing disciplinary review and supervisory investigation by the Minhang district commissions for discipline inspection and supervision in Shanghai. Additionally, Huang Zhenhui, former deputy general manager of SPH NO.1 Biochemical & Pharmaceutical, is being investigated by the Minhang district supervisory committee. As of the announcement date, none of the individuals mentioned are employed by SPH.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=14265#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=14265\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=14265#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations - Insight, China's Pharmaceutical Industry","description":"China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) has disclosed that several former executives are suspected of serious violations of discipline and law. Pan Deqing, the company's former vice-president, Chen Binhua, former general manager of subsidiary SPH NO.1 Biochemical & Pharmaceutical Co., Ltd, and Li Ping, former general manager of subsidiary Shanghai Shangke Pharmaceutical Co., Ltd, are currently undergoing disciplinary review and supervisory investigation by the Minhang district commissions for discipline inspection and supervision in Shanghai. Additionally, Huang Zhenhui, former deputy general manager of SPH NO.1 Biochemical & Pharmaceutical, is being investigated by the Minhang district supervisory committee. As of the announcement date, none of the individuals mentioned are employed by SPH.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=14265","og_locale":"en_US","og_type":"article","og_title":"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=14265","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-09-05T14:50:00+00:00","article_modified_time":"2024-11-22T15:10:56+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=14265#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=14265"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations","datePublished":"2023-09-05T14:50:00+00:00","dateModified":"2024-11-22T15:10:56+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=14265"},"wordCount":276,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["HKG: 2607","SHA: 601607","Shanghai Pharmaceuticals","SPH"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=14265#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=14265","url":"https:\/\/flcube.com\/?p=14265","name":"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-09-05T14:50:00+00:00","dateModified":"2024-11-22T15:10:56+00:00","description":"China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) has disclosed that several former executives are suspected of serious violations of discipline and law. Pan Deqing, the company's former vice-president, Chen Binhua, former general manager of subsidiary SPH NO.1 Biochemical & Pharmaceutical Co., Ltd, and Li Ping, former general manager of subsidiary Shanghai Shangke Pharmaceutical Co., Ltd, are currently undergoing disciplinary review and supervisory investigation by the Minhang district commissions for discipline inspection and supervision in Shanghai. Additionally, Huang Zhenhui, former deputy general manager of SPH NO.1 Biochemical & Pharmaceutical, is being investigated by the Minhang district supervisory committee. As of the announcement date, none of the individuals mentioned are employed by SPH.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=14265#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=14265"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=14265#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/14265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14265"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/14265\/revisions"}],"predecessor-version":[{"id":14266,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/14265\/revisions\/14266"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}